nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCB1—peripheral nervous system neoplasm	0.206	1	CbGaD
Mycophenolate mofetil—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0516	0.101	CbGbCtD
Mycophenolate mofetil—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0489	0.096	CbGbCtD
Mycophenolate mofetil—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0348	0.0683	CbGbCtD
Mycophenolate mofetil—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0339	0.0665	CbGbCtD
Mycophenolate mofetil—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0252	0.0494	CbGbCtD
Mycophenolate mofetil—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0475	CbGbCtD
Mycophenolate mofetil—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0231	0.0453	CbGbCtD
Mycophenolate mofetil—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0215	0.0423	CbGbCtD
Mycophenolate mofetil—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0211	0.0415	CbGbCtD
Mycophenolate mofetil—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0209	0.041	CbGbCtD
Mycophenolate mofetil—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0195	0.0382	CbGbCtD
Mycophenolate mofetil—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0191	0.0375	CbGbCtD
Mycophenolate mofetil—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0176	0.0346	CbGbCtD
Mycophenolate mofetil—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0176	0.0346	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0144	0.0283	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.013	0.0256	CbGbCtD
Mycophenolate mofetil—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0122	0.024	CbGbCtD
Mycophenolate mofetil—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0116	0.0227	CbGbCtD
Mycophenolate mofetil—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0106	0.0208	CbGbCtD
Mycophenolate mofetil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0106	0.0207	CbGbCtD
Mycophenolate mofetil—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0102	0.02	CbGbCtD
Mycophenolate mofetil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00982	0.0193	CbGbCtD
Mycophenolate mofetil—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00752	0.0148	CbGbCtD
Mycophenolate mofetil—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00702	0.0138	CbGbCtD
Mycophenolate mofetil—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00689	0.0135	CbGbCtD
Mycophenolate mofetil—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0047	0.00923	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00451	0.00885	CbGbCtD
Mycophenolate mofetil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00413	0.00811	CbGbCtD
Mycophenolate mofetil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00282	0.00553	CbGbCtD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000114	0.00273	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000112	0.00267	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000109	0.00262	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000109	0.00261	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—GNS—peripheral nervous system neoplasm	0.000109	0.0026	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000108	0.00258	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—NME1—peripheral nervous system neoplasm	0.000104	0.00249	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—COX2—peripheral nervous system neoplasm	0.0001	0.00239	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	9.99e-05	0.00239	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	9.9e-05	0.00237	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.82e-05	0.00235	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.8e-05	0.00234	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—ENO2—peripheral nervous system neoplasm	9.48e-05	0.00227	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.43e-05	0.00226	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	8.91e-05	0.00213	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.85e-05	0.00212	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.76e-05	0.00209	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.76e-05	0.00209	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.59e-05	0.00205	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.55e-05	0.00204	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	8.49e-05	0.00203	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—ENO2—peripheral nervous system neoplasm	8.45e-05	0.00202	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	8.3e-05	0.00199	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	8.2e-05	0.00196	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	8.18e-05	0.00196	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—BCHE—peripheral nervous system neoplasm	8.01e-05	0.00192	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—GNS—peripheral nervous system neoplasm	7.92e-05	0.00189	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—ENO2—peripheral nervous system neoplasm	7.73e-05	0.00185	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.65e-05	0.00183	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NME1—peripheral nervous system neoplasm	7.59e-05	0.00181	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—TH—peripheral nervous system neoplasm	7.53e-05	0.0018	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	7.42e-05	0.00177	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—COX2—peripheral nervous system neoplasm	7.31e-05	0.00175	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.27e-05	0.00174	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.19e-05	0.00172	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.19e-05	0.00172	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—BCHE—peripheral nervous system neoplasm	7.14e-05	0.00171	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	7.07e-05	0.00169	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.81e-05	0.00163	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.75e-05	0.00161	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—TH—peripheral nervous system neoplasm	6.72e-05	0.00161	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.62e-05	0.00158	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.6e-05	0.00158	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.59e-05	0.00158	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—ENO2—peripheral nervous system neoplasm	6.57e-05	0.00157	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—BCHE—peripheral nervous system neoplasm	6.53e-05	0.00156	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.34e-05	0.00152	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.23e-05	0.00149	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—GNAS—peripheral nervous system neoplasm	6.15e-05	0.00147	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—TH—peripheral nervous system neoplasm	6.14e-05	0.00147	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.1e-05	0.00146	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.04e-05	0.00144	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.98e-05	0.00143	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.87e-05	0.0014	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.74e-05	0.00137	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.71e-05	0.00137	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—BCHE—peripheral nervous system neoplasm	5.55e-05	0.00133	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.5e-05	0.00132	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—GNAS—peripheral nervous system neoplasm	5.48e-05	0.00131	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—ABCB1—peripheral nervous system neoplasm	5.38e-05	0.00129	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.3e-05	0.00127	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—TH—peripheral nervous system neoplasm	5.22e-05	0.00125	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—GNAS—peripheral nervous system neoplasm	5.01e-05	0.0012	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.99e-05	0.00119	CbGpPWpGaD
Mycophenolate mofetil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Infestation—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	4.93e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.92e-05	0.00118	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	4.92e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Rash—Dactinomycin—peripheral nervous system neoplasm	4.89e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	4.88e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.86e-05	0.00116	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.86e-05	0.00116	CbGpPWpGaD
Mycophenolate mofetil—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.84e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000198	CcSEcCtD
Mycophenolate mofetil—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000198	CcSEcCtD
Mycophenolate mofetil—Pain—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Constipation—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—ENO2—peripheral nervous system neoplasm	4.8e-05	0.00115	CbGpPWpGaD
Mycophenolate mofetil—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.79e-05	0.00114	CbGpPWpGaD
Mycophenolate mofetil—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.75e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.74e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Sweating—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.62e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.6e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.59e-05	0.0011	CbGpPWpGaD
Mycophenolate mofetil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.59e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Dizziness—Vincristine—peripheral nervous system neoplasm	4.58e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.57e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Rash—Alitretinoin—peripheral nervous system neoplasm	4.53e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.53e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.51e-05	0.000186	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Headache—Alitretinoin—peripheral nervous system neoplasm	4.5e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Urticaria—Etoposide—peripheral nervous system neoplasm	4.46e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.45e-05	0.00106	CbGpPWpGaD
Mycophenolate mofetil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	4.42e-05	0.00106	CbGpPWpGaD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Vomiting—Vincristine—peripheral nervous system neoplasm	4.4e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.39e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.39e-05	0.000181	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.37e-05	0.00105	CbGpPWpGaD
Mycophenolate mofetil—Rash—Vincristine—peripheral nervous system neoplasm	4.37e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.36e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Headache—Vincristine—peripheral nervous system neoplasm	4.34e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	4.32e-05	0.00103	CbGpPWpGaD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.27e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—GNAS—peripheral nervous system neoplasm	4.26e-05	0.00102	CbGpPWpGaD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.19e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.18e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.14e-05	0.00099	CbGpPWpGaD
Mycophenolate mofetil—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.13e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.12e-05	0.000985	CbGpPWpGaD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Nausea—Vincristine—peripheral nervous system neoplasm	4.11e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.07e-05	0.000973	CbGpPWpGaD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—BCHE—peripheral nervous system neoplasm	4.05e-05	0.000969	CbGpPWpGaD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.04e-05	0.000965	CbGpPWpGaD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Asthenia—Etoposide—peripheral nervous system neoplasm	4.03e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.02e-05	0.000961	CbGpPWpGaD
Mycophenolate mofetil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	3.99e-05	0.000953	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.97e-05	0.00095	CbGpPWpGaD
Mycophenolate mofetil—Chills—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Pruritus—Etoposide—peripheral nervous system neoplasm	3.97e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.95e-05	0.000945	CbGpPWpGaD
Mycophenolate mofetil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.94e-05	0.000943	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.93e-05	0.00094	CbGpPWpGaD
Mycophenolate mofetil—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.91e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.89e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.87e-05	0.000925	CbGpPWpGaD
Mycophenolate mofetil—Rash—Cisplatin—peripheral nervous system neoplasm	3.86e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.86e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.84e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—TH—peripheral nervous system neoplasm	3.81e-05	0.000911	CbGpPWpGaD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.79e-05	0.000905	CbGpPWpGaD
Mycophenolate mofetil—Tension—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.77e-05	0.000902	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.76e-05	0.0009	CbGpPWpGaD
Mycophenolate mofetil—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Dizziness—Etoposide—peripheral nervous system neoplasm	3.71e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.71e-05	0.000887	CbGpPWpGaD
Mycophenolate mofetil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.7e-05	0.000884	CbGpPWpGaD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00015	CcSEcCtD
Mycophenolate mofetil—Nausea—Cisplatin—peripheral nervous system neoplasm	3.64e-05	0.00015	CcSEcCtD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.62e-05	0.000866	CbGpPWpGaD
Mycophenolate mofetil—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.62e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000148	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.57e-05	0.000854	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Etoposide—peripheral nervous system neoplasm	3.57e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Rash—Etoposide—peripheral nervous system neoplasm	3.54e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.53e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Headache—Etoposide—peripheral nervous system neoplasm	3.51e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.51e-05	0.000839	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GNS—peripheral nervous system neoplasm	3.51e-05	0.000839	CbGpPWpGaD
Mycophenolate mofetil—Tension—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000143	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.44e-05	0.000822	CbGpPWpGaD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.00014	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.4e-05	0.000812	CbGpPWpGaD
Mycophenolate mofetil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.39e-05	0.000811	CbGpPWpGaD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.37e-05	0.000805	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NME1—peripheral nervous system neoplasm	3.37e-05	0.000805	CbGpPWpGaD
Mycophenolate mofetil—Cough—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.35e-05	0.000802	CbGpPWpGaD
Mycophenolate mofetil—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Nausea—Etoposide—peripheral nervous system neoplasm	3.33e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.3e-05	0.000789	CbGpPWpGaD
Mycophenolate mofetil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.29e-05	0.000787	CbGpPWpGaD
Mycophenolate mofetil—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000133	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.24e-05	0.000775	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—COX2—peripheral nervous system neoplasm	3.24e-05	0.000775	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.22e-05	0.000769	CbGpPWpGaD
Mycophenolate mofetil—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000131	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000131	CcSEcCtD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.17e-05	0.000759	CbGpPWpGaD
Mycophenolate mofetil—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—GNAS—peripheral nervous system neoplasm	3.11e-05	0.000744	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.11e-05	0.000743	CbGpPWpGaD
Mycophenolate mofetil—Shock—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.08e-05	0.000738	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.05e-05	0.00073	CbGpPWpGaD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.04e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.98e-05	0.000712	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.97e-05	0.00071	CbGpPWpGaD
Mycophenolate mofetil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.95e-05	0.000706	CbGpPWpGaD
Mycophenolate mofetil—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.9e-05	0.000695	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.9e-05	0.000694	CbGpPWpGaD
Mycophenolate mofetil—Infection—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000119	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.87e-05	0.000687	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000118	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000118	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.86e-05	0.000683	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.82e-05	0.000674	CbGpPWpGaD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.75e-05	0.000657	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.7e-05	0.000645	CbGpPWpGaD
Mycophenolate mofetil—Constipation—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000111	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000111	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000109	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.65e-05	0.000633	CbGpPWpGaD
Mycophenolate mofetil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.62e-05	0.000626	CbGpPWpGaD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000107	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000107	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000107	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000106	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.57e-05	0.000106	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000105	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.56e-05	0.000611	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.54e-05	0.000608	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000104	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000103	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.5e-05	0.000598	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000103	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.49e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.49e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.45e-05	0.000586	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.45e-05	0.000586	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	9.86e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	9.79e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.34e-05	0.000559	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.32e-05	9.53e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	9.51e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.3e-05	0.000551	CbGpPWpGaD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	9.46e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	9.46e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.26e-05	9.28e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.23e-05	0.000533	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.22e-05	9.15e-05	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.21e-05	0.000529	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.2e-05	0.000526	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.15e-05	8.85e-05	CcSEcCtD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.15e-05	0.000514	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	8.82e-05	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.13e-05	0.00051	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.13e-05	0.000509	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	2.13e-05	0.000509	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.12e-05	0.000508	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.11e-05	0.000505	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.11e-05	0.000505	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	8.59e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.08e-05	8.55e-05	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.08e-05	0.000497	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	8.47e-05	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.05e-05	0.000489	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	2.04e-05	0.000487	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.03e-05	0.000486	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Epirubicin—peripheral nervous system neoplasm	2e-05	8.22e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.99e-05	8.19e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—peripheral nervous system neoplasm	1.98e-05	8.15e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.98e-05	8.15e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—peripheral nervous system neoplasm	1.97e-05	8.1e-05	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.97e-05	0.000471	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.95e-05	0.000466	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	7.91e-05	CcSEcCtD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.92e-05	0.000458	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.88e-05	0.00045	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.87e-05	0.000447	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Epirubicin—peripheral nervous system neoplasm	1.87e-05	7.68e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.85e-05	7.61e-05	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.85e-05	0.000442	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.85e-05	0.000441	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.84e-05	0.00044	CbGpPWpGaD
Mycophenolate mofetil—Rash—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	7.55e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.83e-05	7.54e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	7.5e-05	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.8e-05	0.000432	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.00043	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.00043	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.78e-05	0.000426	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.77e-05	0.000424	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.76e-05	0.000421	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.73e-05	7.11e-05	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.71e-05	0.00041	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.71e-05	0.00041	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-05	0.000408	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.7e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.7e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.7e-05	0.000406	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.69e-05	0.000404	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	1.69e-05	0.000404	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.000402	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.67e-05	0.000398	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000397	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.65e-05	0.000394	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.61e-05	0.000385	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.000376	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.55e-05	0.00037	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.54e-05	0.000369	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.54e-05	0.000369	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.52e-05	0.000365	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.51e-05	0.000362	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.49e-05	0.000355	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.48e-05	0.000354	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.45e-05	0.000348	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.43e-05	0.000343	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.00033	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.00033	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.37e-05	0.000328	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.35e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.35e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000323	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.32e-05	0.000317	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.29e-05	0.000309	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000302	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.000297	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.24e-05	0.000296	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.00028	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000275	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.000275	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.12e-05	0.000268	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.11e-05	0.000266	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.09e-05	0.000261	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.09e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.04e-05	0.000249	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.92e-06	0.000237	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.76e-06	0.000233	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.51e-06	0.000227	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	9.46e-06	0.000226	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	9.41e-06	0.000225	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.33e-06	0.000223	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.18e-06	0.00022	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	9.16e-06	0.000219	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.03e-06	0.000216	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.98e-06	0.000215	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	8.9e-06	0.000213	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TH—peripheral nervous system neoplasm	8.85e-06	0.000212	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—peripheral nervous system neoplasm	8.4e-06	0.000201	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	8.39e-06	0.000201	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	8.24e-06	0.000197	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	8.23e-06	0.000197	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.86e-06	0.000188	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.75e-06	0.000185	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	7.44e-06	0.000178	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	7.26e-06	0.000174	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	7.22e-06	0.000173	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.13e-06	0.00017	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	7.09e-06	0.000169	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.33e-06	0.000151	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.01e-06	0.000144	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	5.69e-06	0.000136	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	5.44e-06	0.00013	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.08e-06	0.000121	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	5.08e-06	0.000121	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.85e-06	0.000116	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.81e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.78e-06	0.000114	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	4.58e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.9e-06	9.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.83e-06	9.15e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.72e-06	8.9e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	3.72e-06	8.9e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.41e-06	8.16e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.16e-06	7.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.26e-06	5.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.96e-06	4.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.95e-06	4.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.71e-06	4.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.05e-06	2.52e-05	CbGpPWpGaD
